AMRX

Amneal Pharmaceuticals
AMRX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$2.43B
EV
$5.02B
Shares Outstanding
314.17M
Beta
1.05

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$11.75
P/E 2025E
11.00x
P/Revenue 2025E
0.81x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Amneal Pharmaceuticals, Inc.

gainify
AMRX

Amneal Pharmaceuticals, Inc.

AMRX

Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide. The company operates through three segments: Generics, Specialty...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Data Unavailable

Employees

8,300

Website

amneal.com

IPO Date

2018-05-07

Headquarters

400 Crossing Boulevard, 3rd Floor, Bridgewater, New Jersey, 08807, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.